Fatal Liver Failure Secondary to Chemotherapy Induced Hepatitis-B Virus Reactivation in a Patient with Acute Myeloid Leukemia

References (12)

1. Rossi G, Pelizzari A, Motta M et al. Primary prophylaxis with lamuvidine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. British Journal of Haematology 115: 58-62, 2001
2. Yeo W, Chan PKS, Zhong S et al. Frequency of hepatitis B virus reactivation in cancer patient undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. Journal of Medical Virology 62: 299-307, 2000
3. Xunrong L, Yan AW, Liang R et al. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy, pathogenesis and management. Rev Med Virol 11: 287-99, 2001
4. Ohtsu T, Sai T, Oka M et al. Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B carriers with hematologic malignancies. Journal of Clinical Oncology 21: 360-5, 1991
5. Cheng AL. Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin’s lymphoma. Blood 87: 1202, 1996
6. Al-Taie OH, Mork H, Gassel AM et al. Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature. Ann Hematol 78: 247-91, 1999
7. Kawai Y, Ikegaya S, Hata M et al. Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin’s lymphoma: case report and review of the literature. Ann Hematol 80: 482-4, 2001
8. Ahmed A, Keeffe EB. Lamuvidine therapy for chemotherapyinduced reactivation of hepatitis B virus infection. Am J Gastroenterol 94: 249-51, 1999
9. Saif MW, Little RF, Hamilton JM et al. Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of the literature. Ann Oncol 12: 123-9, 2001
10. Maguire CM, Crawford DH, Hourigan LF et al. Case report: lamuvidine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy. J Gastroenterol Hepatol 14: 801-4, 1999
11. Shtalrid M, Haran M, Klepfish A et al. Effective treatment with lamivudine of patients with reactivation of hepatitis B following chemotherapy administration. Harefuah 140: 1159-62, 2001 (Abstract)
12. Clark FL, Drummond MW, Chambers S et al. Successful treatment with lamivudine for fulminant reactivation of hepatitis B infection following intensive therapy for high-grade non-Hodgkin’s lymphoma. Ann Oncol 9: 385-7, 1